Beyond Signaling Risk, Blood Pressure and Obesity Causally Related to Lifespan

Published: Wednesday, October 16, 2019, 5:30 p.m. U.S. Central Time

Media Contact: Ann Klinck, 301.634.7342, press@ashg.org

Findings Reported at ASHG 2019 Annual Meeting

Saori Sakaue, MD, PhD candidate at Osaka University
(courtesy Dr. Sakaue)

HOUSTON, Texas – Researchers are exploring the cause and effect relationships between common health indicators and lifespan, by analyzing polygenic risk scores (PRS), a numerical score of a person’s risk for disease based on multiple genetic variants. Saori Sakaue, MD, a PhD candidate at Osaka University, and her mentor Professor Yukinori Okada, recently showed that in addition to signaling inherited risk of a disease, PRS revealed that blood pressure and obesity are themselves causally related to lifespan. The research was presented at the American Society of Human Genetics 2019 Annual Meeting in Houston, Texas.

“Meeting patients around the world, I’ve found that people want to understand their genetic risk,” Dr. Sakaue said. “When you find you are at a high risk for a disease, it is great to know your future health risk but obviously you cannot modify the inherited genetic risk. I wanted to find something that we could also modify to improve outcomes, such as lengthening lifespan, by utilizing the genetic data in a population scale.”

To find a clinically actionable indicator of genetic risk, Dr. Sakaue and her team started by examining samples from BioBank Japan, which has a heavy East Asian representation. They used the genetic data of 180,000 people to perform genome-wide association studies for 45 common health indicators. By analyzing the PRS of each indicator, they identified the ones that most strongly affected lifespan.

“If you only look at raw clinical data associated to lifespan, you cannot show which attribute is cause and which is effect,” Dr. Sakaue said. “For instance, when a patient is dying, their blood pressure is low, so you can’t necessarily know if blood pressure is the cause of their death. By using PRS, we can get closer to identifying the cause, because PRS is less susceptible to the acquired confounding factors such as decline in general health.”

For the individuals in BioBank Japan, Dr. Sakaue and colleagues found that high blood pressure and obesity had the most significant associations to reduced lifespan.

To improve the diversity of their study and ensure that these associations held across populations, the researchers collaborated with the UK Biobank and FinnGen, and performed a trans-ethnic association study of PRS and lifespan. This increased the sample size to 700,000 and, with the help of additional analyses, reinforced the conclusion that blood pressure and obesity are causally related to reduced lifespan.

The researchers emphasized that while blood pressure and obesity are heritable traits, they can also be monitored and modified. “Obesity and blood pressure can be modified through lifestyle changes and medications. So, a clinician can tell his or her patients that genetics research suggests modifying these areas may help extend lifespan, in order to encourage their lifestyle changes,” said Dr. Sakaue.

Dr. Sakaue’s next steps in this research are to collaborate with more biobanks to grow the genetic diversity of their data and find more clinically actionable causal factors. She hopes that beyond identifying someone’s risk for a disease, her team can use biobank information to improve health.

Media Interest: To learn more about Dr. Sakaue’s work or set up an interview, please contact press@ashg.org to coordinate.

Reference: S Sakaue et al. (2019 Oct 16). Abstract: Trans-ethnic mega-biobank polygenic risk score analysis involving 676,000 individuals identified blood pressure and obesity as causal drivers affecting human longevity. Presented at the American Society of Human Genetics 2019 Annual Meeting. Houston, Texas.

About the American Society of Human Genetics (ASHG)

Founded in 1948, the American Society of Human Genetics is the primary professional membership organization for human genetics specialists worldwide. Its nearly 8,000 members include researchers, academicians, clinicians, laboratory practice professionals, genetic counselors, nurses, and others with an interest in human genetics. The Society serves scientists, health professionals, and the public by providing forums to: (1) share research results through the ASHG Annual Meeting and in The American Journal of Human Genetics; (2) advance genetic research by advocating for research support; (3) educate current and future genetics professionals, health care providers, advocates, policymakers, educators, students, and the public about all aspects of human genetics; and (4) promote genetic services and support responsible social and scientific policies. For more information, visit: http://www.ashg.org.

6120 Executive Blvd, Suite 500 | Rockville, MD 20852 | 301.634.7300 | society@ashg.org | www.ashg.org
Connect with ASHG on Twitter (@GeneticsSociety) | Facebook | LinkedIn

ASHG uses cookies to provide you with a secure and custom web experience. Privacy Policy